Merck | MRK - Current Liabilities



Merck reported EUR9.86B in Current Liabilities for its fiscal quarter ending in June of 2025.


Current Liabilities Change Date
Adidas EUR 8.96B 19M Jun/2025
Adyen EUR 7.02B 698.9M Dec/2024
Akzo Nobel EUR 5.16B 371M Jun/2025
Alcon AG USD 2.42B 178M Jun/2025
Amadeus IT EUR 2.36B 180.1M Jun/2025
Amarin USD 162.41M 17.54M Mar/2025
AstraZeneca USD 33.54B 4.41B Jun/2025
BASF EUR 18.18B 74M Jun/2025
Bayer EUR 29.78B 1.82B Jun/2025
Beiersdorf EUR 3.77B 6.12B Jun/2025
Covestro EUR 4.04B 719M Jun/2025
Danone EUR 13.62B 116M Jun/2025
Fresenius EUR 8.3B 33M Jun/2025
Fresenius Medical Care EUR 5.66B 213.7M Jun/2025
Galapagos EUR 402.95M 34.09M Jun/2025
Genmab DKK 629M 127M Jun/2025
Givaudan CHF 2.97B 911M Jun/2024
GlaxoSmithKline GBP 20.38B 453M Jun/2025
GRIFOLS EUR 1.99B 180.07M Jun/2025
Henkel EUR 8.54B 549M Jun/2025
Hikma Pharmaceutical USD 1.98B 598M Dec/2024
Infineon EUR 5.43B 608M Jun/2025
Linde USD 14.71B 170M Jun/2025
Lonza CHF 3.58B 970M Dec/2024
Merck EUR 9.86B 357M Jun/2025
Novartis USD 31.71B 95M Jun/2025
Philips EUR 7.2B 445M Jun/2025
Roche Holding CHF 27.02B 424M Dec/2024
Sanofi 29.06B 3.16B Jun/2025
UCB EUR 3.53B 731M Dec/2024